Etiket: BioNTech
Outlook: BioNTech (ADRs) reports figures for the most recent quarter
shares in this article BioNTech (ADRs) will report on 05/08/2023 financial results for the quarter ended 03/31/2023. On average, 10 analysts are forecasting earnings per share of EUR 0.265 compared…
GNW-Adhoc: BioNTech will publish results for the 2022 financial year on March 27, 2023 and provide information on operational progress in the fourth quarter
shares in this article ^MAINZ, Germany, March 13, 2023 (GLOBE NEWSWIRE) – BioNTech SE (https://biontech.de/) (Nasdaq: BNTX,?BioNTech” or?the company”) will be Monday, March 27, 2023, the results of the financial…
Hot Stocks today: BioNTech stock is attractive again – PWO 50% potential
Today on the finanzen.net podcast, Hot Bets, we are talking about BioNTech and PWO stocks. For more details, have a listen!
BioNTech wants to produce vaccines in Rwanda from 2024 – BioNTech shares firmer before the market
shares in this article In the course of 2024, the production of the Covid-19 vaccine from BioNTech and Pfizer should start there in the capital Kigali, the company announced during…
Pfizer, BioNTech and Moderna stocks lose: EMA clears the way for corona vaccines for babies
shares in this article With the vaccines from the manufacturers Pfizer/BioNTech or Moderna, such children could also be protected from corona infection, the EMA announced on Wednesday in Amsterdam. Both…
“Vaccines to treat cancer may be possible by 2030”"founders of BioNTech . report
Cancer vaccines could be available before the end of the decade, say the team behind one of the pandemic’s most successful Covid vaccines. Uğur Şahin and Özlem Türeci, founders of…
EMA approves Moderna and Biontech omicron vaccines
Prepared syringes with the vaccine from Biontech/Pfizer (symbolic photo) Photo: fru sb From BZ/afp and BZ/Reuters Corona vaccines adapted to the Omicron variant can now also be used in the…
After a price drop in BioNTech shares: why autumn could be hot
shares in this article by Julia Groß, Euro am Sonntag Dhe cooling in the Covid-19 vaccine market can no longer be overlooked. In the second quarter, the Mainz-based…
BioNTech stock up: BioNTech’s Omicron vaccine is set to ship soon
shares in this article “We can deliver very promptly, hopefully from the beginning of September,” company boss Ugur Sahin told the “Spiegel”. The EMA recently announced that the responsible committee…
BioNTech and Pfizer shares ultimately still weak: EMA reviews BioNTech’s Omicron vaccine
shares in this article This is done as part of a so-called rolling review process, said a spokesman for the authority on request. Results are already evaluated if no complete…